Bukwang Pharm (Korea) Today
| 003000 Stock | 4,860 215.00 4.63% |
Performance0 of 100
| Odds Of DistressLess than 37
|
Bukwang Pharm is trading at 4860.00 as of the 28th of November 2024, a 4.63 percent up since the beginning of the trading day. The stock's open price was 4645.0. Bukwang Pharm has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Bukwang Pharm are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Moving together with Bukwang Stock
Moving against Bukwang Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bukwang Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bukwang Pharm's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bukwang Pharm or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals (View all Sectors) |
Bukwang Pharm (003000) is traded on Korea Stock Exchange in Korea and employs 568 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 627.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bukwang Pharm's market, we take the total number of its shares issued and multiply it by Bukwang Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bukwang Pharm has 68.45 M outstanding shares.
Bukwang Pharm generates positive cash flow from operations, but has no cash available
Check Bukwang Pharm Probability Of Bankruptcy
Ownership AllocationBukwang Pharm holds a total of 68.45 Million outstanding shares. Bukwang Pharm retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bukwang Ownership Details
Bukwang Pharm Risk Profiles
Although Bukwang Pharm's alpha and beta are two of the key measurements used to evaluate Bukwang Pharm's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.43 | |||
| Standard Deviation | 2.07 | |||
| Variance | 4.29 | |||
| Risk Adjusted Performance | (0.03) |
Bukwang Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bukwang Pharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Bukwang Pharm Corporate Directors
| WonTae Park | Managing Director | Profile | |
| HeeSang Lee | Managing Director | Profile | |
| GeumSeo Gu | Managing Director | Profile | |
| YoungChoon Lee | Managing Director | Profile |
Other Information on Investing in Bukwang Stock
Bukwang Pharm financial ratios help investors to determine whether Bukwang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bukwang with respect to the benefits of owning Bukwang Pharm security.